In­di­v­ior ax­es schiz­o­phre­nia drug and shrinks rev­enue guid­ance

In­di­v­ior’s shares $IN­DV have lost near­ly a third of their val­ue this week, fol­low­ing the com­pa­ny’s an­nounce­ment Tues­day that it was shelv­ing a schiz­o­phre­nia drug …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER